Bukwang Pharmaceutical Balance Sheet Health
Financial Health criteria checks 4/6
Bukwang Pharmaceutical has a total shareholder equity of ₩229.0B and total debt of ₩78.9B, which brings its debt-to-equity ratio to 34.4%. Its total assets and total liabilities are ₩348.8B and ₩119.8B respectively.
Key information
34.4%
Debt to equity ratio
₩78.87b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩117.60b |
| Equity | ₩228.97b |
| Total liabilities | ₩119.83b |
| Total assets | ₩348.80b |
Recent financial health updates
Bukwang Pharmaceutical (KRX:003000) Has Debt But No Earnings; Should You Worry?
Nov 13
Is Bukwang Pharmaceutical (KRX:003000) Weighed On By Its Debt Load?
May 22Is Bukwang Pharmaceutical (KRX:003000) A Risky Investment?
Feb 10Recent updates
Bukwang Pharmaceutical (KRX:003000) Has Debt But No Earnings; Should You Worry?
Nov 13Is Bukwang Pharmaceutical (KRX:003000) Weighed On By Its Debt Load?
May 22Investors In Bukwang Pharmaceutical Co., Ltd. (KRX:003000) Should Consider This, First
Apr 03Did Bukwang Pharmaceutical's (KRX:003000) Share Price Deserve to Gain 71%?
Mar 08Is Bukwang Pharmaceutical (KRX:003000) A Risky Investment?
Feb 10How Much Of Bukwang Pharmaceutical Co., Ltd. (KRX:003000) Do Insiders Own?
Jan 14Does It Make Sense To Buy Bukwang Pharmaceutical Co., Ltd. (KRX:003000) For Its Yield?
Dec 19Did You Miss Bukwang Pharmaceutical's (KRX:003000) 90% Share Price Gain?
Nov 23Financial Position Analysis
Short Term Liabilities: A003000's short term assets (₩195.1B) exceed its short term liabilities (₩28.5B).
Long Term Liabilities: A003000's short term assets (₩195.1B) exceed its long term liabilities (₩91.3B).
Debt to Equity History and Analysis
Debt Level: A003000 has more cash than its total debt.
Reducing Debt: A003000's debt to equity ratio has increased from 0% to 34.4% over the past 5 years.
Debt Coverage: A003000's debt is well covered by operating cash flow (51.3%).
Interest Coverage: Insufficient data to determine if A003000's interest payments on its debt are well covered by EBIT.